EarlyCell
About:
EarlyCell is a biotechnology company that develops genetic and expression diagnostics for unmet or poorly diagnosed conditions.
Description:
EarlyCell is a biotechnology company that develops genetic and expression diagnostics for unmet or poorly diagnosed conditions. The company's technology is focused on rare cells and modern molecular genetic and expression analysis (NGS, microarray, and FACS). It was founded in 2015 and is headquartered in Cleveland, Ohio, USA.
Total Funding Amount:
$800000
Headquarters Location:
Cleveland, Ohio, United States
Founded Date:
2015-01-01
Founders:
David Jackson, Ken Reed
Number of Employees:
1-10
Last Funding Date:
2015-06-25
IPO Status:
Private
Industries:
© 2025 bioDAO.ai